Global mRNA Vaccines & Therapeutics Sales Market Report 2020

Global mRNA Vaccines & Therapeutics Sales Market Report 2020

Jun 2020 QYResearch Pharmaceutical140 Pages Price :
$ 4000

Market Analysis and Insights: Global mRNA Vaccines & Therapeutics Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the mRNA Vaccines & Therapeutics market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
Global mRNA Vaccines & Therapeutics Scope and Market Size
The global mRNA Vaccines & Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Vaccines & Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2021-2032.

By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

Segment by Type
Infectious Disease Vaccines
Cancer Vaccines

Segment by Application
Infectious Disease
Cancer

By Region
North America
Europe
China
Japan
Korea
India



1 MRNA VACCINES & THERAPEUTICS MARKET OVERVIEW1
1.1 mRNA Vaccines & Therapeutics Product Scope1
1.2 mRNA Vaccines & Therapeutics Segment by Type1
1.2.1 Global mRNA Vaccines & Therapeutics Sales by Type (2021 & 2032)2
1.2.2 Infectious Disease Vaccines3
1.2.3 Cancer Vaccines3
1.3 mRNA Vaccines & Therapeutics Segment by Application3
1.3.1 Global mRNA Vaccines & Therapeutics Sales Comparison by Application (2021-2032)4
1.3.2 Infectious Disease5
1.3.3 Cancer6
1.4 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts (2021-2032)7
1.4.1 Global mRNA Vaccines & Therapeutics Revenue Growth Rate (2021-2032)7
1.4.2 Global mRNA Vaccines & Therapeutics Sales Growth Rate (2021-2032)7
1.4.3 Global mRNA Vaccines & Therapeutics Price Trends (2021-2032)8
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth8
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections8
1.5.2 Covid-19 Impact: Commodity Prices Indices17
1.5.3 Covid-19 Impact: Global Major Government Policy21
2 MRNA VACCINES & THERAPEUTICS ESTIMATES AND FORECASTS BY REGION26
2.1 Global mRNA Vaccines & Therapeutics Market Size by Region: 2021 VS 2027 VS 203226
2.2 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario by Region (2021-2026)27
2.2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2021-2026)27
2.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2021-2026)28
2.3 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Region (2027-2032)30
2.3.1 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts by Region (2027-2032)30
2.3.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2027-2032)31
2.4 Geographic Market Analysis: Market Facts & Figures33
2.4.1 North America mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)33
2.4.2 Europe mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)34
2.4.3 China mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)35
2.4.4 Japan mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)36
2.4.5 Korea mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)37
2.4.6 India mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)38
3 MRNA VACCINES & THERAPEUTICS COMPETITION LANDSCAPE BY PLAYERS39
3.1 Manufacturers mRNA Vaccines & Therapeutics Headquarter, Founded Time39
3.2 Manufacturers mRNA Vaccines & Therapeutics Product Type, Research Stage, Treatment Area39
3.3 Main Pipeline Product Analysis40
3.3.1 IVAC-Mutanome40
3.3.2 FixVax40
3.3.3 CV810241
3.3.4 CV720141
3.3.5 AGS-00441
3.3.6 MRT5005 & MRT520142
3.3.7 SB-FIX & SB-318 & SB-91343
3.3.8 Moderna Therapeutics Pipeline44
3.4 Manufacturers Mergers & Acquisitions, Expansion Plans45
3.5 Companies with mRNA Programs47
3.5.1 Alexion Pharmaceuticals47
3.5.2 Vertex Pharmaceuticals48
3.5.3 Ultragenyx Pharmaceutical49
3.6 Companies focus on mRNA Delivery50
3.6.1 Acuitas Therapeutics50
3.6.2 Silence Therapeutics51
3.6.3 Arcturus Therapeutics53
3.7 Major Pharmaceutical Companies with mRNA Programs54
3.7.1 Boehringer Ingelheim54
3.7.2 Novartis55
3.7.3 Merck56
3.7.4 AstraZeneca57
3.7.5 Roche58
3.7.6 Sanofi59
3.7.7 Takeda60
3.7.8 Johnson & Johnson61
3.7.9 Bayer62
3.7.10 ZIOPHARM Oncology63
3.7.11 MaxCyte64
3.7.12 Casebia Therapeutics66
3.7.13 Intellia Therapeutics68
4 MRNA VACCINES & THERAPEUTICS MARKET SIZE BY TYPE70
4.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Type (2021-2026)70
4.1.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)70
4.1.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2021-2026)70
4.1.3 Global mRNA Vaccines & Therapeutics Price by Type (2021-2026)71
4.2 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Type (2027-2032)71
4.2.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2027-2032)71
4.2.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2027-2032)72
4.2.3 Global mRNA Vaccines & Therapeutics Price Forecast by Type (2027-2032)72
5 MRNA VACCINES & THERAPEUTICS MARKET SIZE BY APPLICATION73
5.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Application (2021-2026)73
5.2 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Application (2027-2032)73
6 NORTH AMERICA MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES75
6.1 North America mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)75
6.2 North America mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)76
7 EUROPE MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES77
7.1 Europe mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)77
7.2 Europe mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)78
8 CHINA MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES79
8.1 China mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)79
8.2 China mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)80
9 JAPAN MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES81
9.1 Japan mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)81
9.2 Japan mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)82
10 KOREA MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES83
10.1 Korea mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)83
10.2 Korea mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)84
11 INDIA MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES85
11.1 India mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)85
11.2 India mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)86
12 ANALYSIS OF MRNA VACCINES & THERAPEUTICS INDUSTRY KEY MANUFACTURERS87
12.1 Moderna Therapeutics87
12.1.1 Company Profile87
12.1.2 Product Information88
12.2 CureVac89
12.2.1 Company Profile89
12.2.2 Product Information90
12.3 Translate Bio90
12.3.1 Company Profile90
12.3.2 Product Information92
12.4 BioNTech92
12.4.1 Company Profile92
12.4.2 Product Information93
12.5 Sangamo Therapeutics94
12.5.1 Company Profile94
12.5.2 Product Information95
12.6 Argos Therapeutics95
12.6.1 Company Profile95
12.6.2 Product Information96
12.7 In-Cell-Art96
12.7.1 Company Profile96
12.7.2 Product Information98
12.8 ETheRNA98
12.8.1 Company Profile98
12.8.2 Product Information99
12.9 Ethris100
12.9.1 Company Profile100
12.9.2 Product Information101
12.10 Tiba Biotechnology101
12.10.1 Company Profile101
12.10.2 Product Information102
13 MRNA VACCINES & THERAPEUTICS MANUFACTURING COST ANALYSIS103
13.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis103
13.1.1 Key Raw Materials Price Trend104
13.1.2 Key Suppliers of Raw Materials105
13.2 Proportion of Manufacturing Cost Structure106
13.3 Comparison of Production Processes for Traditional, mRNA and DNA Vaccines107
13.4 mRNA Vaccines & Therapeutics Industrial Chain Analysis109
14 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS110
14.1 Marketing Channel110
14.2 mRNA Vaccines & Therapeutics Distributors List112
14.3 mRNA Vaccines & Therapeutics Customers113
15 MARKET DYNAMICS114
15.1 Covid-19 Impact: mRNA Vaccines & Therapeutics Market Trends114
15.2 Covid-19 Impact: mRNA Vaccines & Therapeutics Opportunities and Drivers116
15.3 Covid-19 Impact: mRNA Vaccines & Therapeutics Market Challenges116
15.4 Porter's Five Forces Analysis116
16 RESEARCH FINDINGS AND CONCLUSION118
17 APPENDIX119
17.1 Research Methodology119
17.1.1 Methodology/Research Approach119
17.1.2 Data Source122
17.2 Author Details125
17.3 Disclaimer125

List of Table


Table 1. Global mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate by Type (2021 & 2032)2
Table 2. Scope of Clinical mRNA Applications3
Table 3. Global mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate by Application (2021 & 2032)4
Table 4. Overview of the World Economic Outlook Projections10
Table 5. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)12
Table 6. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)13
Table 7. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)14
Table 8. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)15
Table 9. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)17
Table 10. Covid-19 Impact: Global Major Government Policy22
Table 11. Global Market mRNA Vaccines & Therapeutics Market Size (US$ Million) by Region:2021 VS 2027 &203226
Table 12. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Region (2021-2026)27
Table 13. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2021-2026)27
Table 14. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Region (2021-2026)28
Table 15. Global mRNA Vaccines & Therapeutics Revenue Share by Region (2021-2026)28
Table 16. Global mRNA Vaccines & Therapeutics Sales (M Doses) Forecast by Region (2027-2032)30
Table 17. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Region (2027-2032)30
Table 18. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Forecast by Region (2027-2032)31
Table 19. Global mRNA Vaccines & Therapeutics Revenue Share Forecast by Region (2027-2032)31
Table 20. Manufacturers mRNA Vaccines & Therapeutics Headquarter, Founded Time39
Table 21. Manufacturers mRNA Vaccines & Therapeutics Product Type, Research Stage, Treatment Area39
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans45
Table 23. Alexion Pharmaceuticals Company Profile47
Table 24. Vertex Pharmaceuticals Company Profile48
Table 25. Ultragenyx Pharmaceutical Company Profile49
Table 26. Acuitas Therapeutics Company Profile50
Table 27. Silence Therapeutics Company Profile51
Table 28. Product Information52
Table 29. Arcturus Therapeutics Company Profile53
Table 30. Product Information54
Table 31. Boehringer Ingelheim Company Profile54
Table 32. Novartis Company Profile55
Table 33. Merck Company Profile56
Table 34. AstraZeneca Company Profile57
Table 35. Roche Company Profile58
Table 36. Sanofi Company Profile59
Table 37. Takeda Company Profile60
Table 38. Johnson & Johnson Company Profile61
Table 39. Bayer Company Profile62
Table 40. ZIOPHARM Oncology Company Profile63
Table 41. MaxCyte Company Profile64
Table 42. Casebia Therapeutics Company Profile66
Table 43. Intellia Therapeutics Company Profile68
Table 44. Product Information69
Table 45. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Type (2021-2026)70
Table 46. Global mRNA Vaccines & Therapeutics Sales Share by Type (2021-2026)70
Table 47. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Type (2021-2026)70
Table 48. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2021-2026)71
Table 49. Global mRNA Vaccines & Therapeutics Price (M Doses) by Type (2021-2026)71
Table 50. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Type (2027-2032)71
Table 51. Global mRNA Vaccines & Therapeutics Sales Share by Type (2027-2032)71
Table 52. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Type (2027-2032)72
Table 53. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2027-2032)72
Table 54. Global mRNA Vaccines & Therapeutics Price (M Doses) by Type (2027-2032)72
Table 55. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Application (2021-2026)73
Table 56. Global mRNA Vaccines & Therapeutics Sales Share by Application (2021-2026)73
Table 57. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Application (2027-2032)73
Table 58. Global mRNA Vaccines & Therapeutics Sales Share by Application (2027-2032)74
Table 59. North America mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)75
Table 60. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)75
Table 61. North America mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)75
Table 62. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)75
Table 63. North America mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)76
Table 64. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)76
Table 65. North America mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)76
Table 66. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)76
Table 67. Europe mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)77
Table 68. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)77
Table 69. Europe mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)77
Table 70. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)77
Table 71. Europe mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)78
Table 72. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)78
Table 73. Europe mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)78
Table 74. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)78
Table 75. China mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)79
Table 76. China mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)79
Table 77. China mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)79
Table 78. China mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)79
Table 79. China mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)80
Table 80. China mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)80
Table 81. China mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)80
Table 82. China mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)80
Table 83. Japan mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)81
Table 84. Japan mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)81
Table 85. Japan mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)81
Table 86. Japan mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)81
Table 87. Japan mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)82
Table 88. Japan mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)82
Table 89. Japan mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)82
Table 90. Japan mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)82
Table 91. Korea mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)83
Table 92. Korea mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)83
Table 93. Korea mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)83
Table 94. Korea mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)83
Table 95. Korea mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)84
Table 96. Korea mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)84
Table 97. Korea mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)84
Table 98. Korea mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)84
Table 99. India mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)85
Table 100. India mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)85
Table 101. India mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)85
Table 102. India mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)85
Table 103. India mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)86
Table 104. India mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)86
Table 105. India mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)86
Table 106. India mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)86
Table 107. Moderna Therapeutics Company Profile87
Table 108. CureVac Company Profile89
Table 109. Translate Bio Company Profile90
Table 110. BioNTech Company Profile92
Table 111. Sangamo Therapeutics Company Profile94
Table 112. Argos Therapeutics Company Profile95
Table 113. In-Cell-Art Company Profile96
Table 114. ETheRNA Company Profile98
Table 115. Ethris Company Profile100
Table 116. Tiba Biotechnology Company Profile101
Table 117. Out-of-pocket Preclinical and Clinical Period Cost Per Investigational Biopharmaceutical Compound105
Table 118. Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound106
Table 119. mRNA Vaccines & Therapeutics Customers List113
Table 120. Covid-19 Impact: mRNA Vaccines & Therapeutics Market Key Trends114
Table 121. Covid-19 Impact: mRNA Vaccines & Therapeutics Key Opportunities and Drivers116
Table 122. Covid-19 Impact: mRNA Vaccines & Therapeutics Market Challenges116
Table 123. Research Programs/Design for This Report119
Table 124. Key Data Information from Secondary Sources122
Table 125. Key Data Information from Primary Sources124
Figure 1. mRNA Vaccines & Therapeutics Product Picture1
Figure 2. Global mRNA Vaccines & Therapeutics Market Share by Type in 20272
Figure 3. Global mRNA Vaccines & Therapeutics Market Share by Type in 20323
Figure 4. Global mRNA Vaccines & Therapeutics Market Share by Application in 20274
Figure 5. Global mRNA Vaccines & Therapeutics Market Share by Application in 20325
Figure 6. Infectious Disease Examples5
Figure 7. Cancer Examples6
Figure 8. Global mRNA Vaccines & Therapeutics Revenue, (US$ Million), 2021 VS 2027 VS 20327
Figure 9. Global mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)7
Figure 10. Global mRNA Vaccines & Therapeutics Price Trends Growth Rate (2021-2032) & (USD/Doses)8
Figure 11. Commodity Prices-Metals Price Indices18
Figure 12. Commodity Prices- Precious Metal Price Indices18
Figure 13. Commodity Prices- Agricultural Raw Material Price Indices19
Figure 14. Commodity Prices- Food and Beverage Price Indices19
Figure 15. Commodity Prices- Fertilizer Price Indices20
Figure 16. Commodity Prices- Energy Price Indices21
Figure 17. G20+: Economic Policy Responses to COVID-1921
Figure 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 202129
Figure 19. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 202629
Figure 20. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 202732
Figure 21. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 203232
Figure 22. North America mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)33
Figure 23. North America mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)33
Figure 24. Europe mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)34
Figure 25. Europe mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)34
Figure 26. China mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)35
Figure 27. China mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)35
Figure 28. Japan mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)36
Figure 29. Japan mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)36
Figure 30. Korea mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)37
Figure 31. Korea mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)37
Figure 32. India mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)38
Figure 33. India mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)38
Figure 34. IVAC-Mutanome Pipeline40
Figure 35. FixVax Pipeline40
Figure 36. CV8102 Pipeline41
Figure 37. CV7201 Pipeline41
Figure 38. CV7201 Pipeline41
Figure 39. MRT5005 & MRT5201 Pipeline42
Figure 40. SB-FIX Pipeline43
Figure 41. SB-318 & SB-913 Pipeline43
Figure 42. Moderna Therapeutics Pipeline44
Figure 43. mRNA Vaccines & Therapeutics Product Information of Acuitas Therapeutics51
Figure 44. mRNA Vaccines & Therapeutics Product Information of ZIOPHARM Oncology64
Figure 45. mRNA Vaccines & Therapeutics Product Information of Casebia Therapeutics67
Figure 46. mRNA Vaccines & Therapeutics Product Picture of Moderna Therapeutics88
Figure 47. mRNA Vaccines & Therapeutics Product Picture of CureVac90
Figure 48. mRNA Vaccines & Therapeutics Product Picture of Translate Bio92
Figure 49. mRNA Vaccines & Therapeutics Product Picture of BioNTech93
Figure 50. mRNA Vaccines & Therapeutics Product Picture of Sangamo Therapeutics95
Figure 51. mRNA Vaccines & Therapeutics Product Picture of Argos Therapeutics96
Figure 52. mRNA Vaccines & Therapeutics Product Picture of In-Cell-Art98
Figure 53. mRNA Vaccines & Therapeutics Product Picture of ETheRNA99
Figure 54. mRNA Vaccines & Therapeutics Product Picture of Ethris101
Figure 55. mRNA Vaccines & Therapeutics Product Picture of Tiba Biotechnology102
Figure 56. Typical Phases from Research to the Market for a Cancer Vaccine Candidate104
Figure 57. Manufacturing Cost Structure of mRNA Vaccines & Therapeutics106
Figure 58. Comparison of Production Processes for Traditional, mRNA and DNA Vccines107
Figure 59. Differences between Traditional, mRNA and DNA Vaccines107
Figure 60. History of Vaccine Development108
Figure 61. Differences between Traditional, MRNA and DNA Vaccines (Delivery)108
Figure 62. mRNA Vaccines & Therapeutics Industrial Chain Analysis109
Figure 63. Channels of Distribution111
Figure 64. Distributors Profiles112
Figure 65. Porter's Five Forces Analysis117
Figure 66. Bottom-up and Top-down Approaches for This Report121
Figure 67. Data Triangulation122
Figure 68. Key Executives Interviewed124

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 4000
$ 6000

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top